Irritable Bowel Syndrome and Digestive Health Support Forum banner

Medical News Today- Salix Pharmaceuticals Announces NDA Submission For XIFAXAN550 For Treatment Of Non-Constipation Irritable Bowel Syndrome

Jump to Latest Follow
1 - 1 of 1 Posts
V

·
Banned
Joined
·
0 Posts
Discussion Starter · #1 ·
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company has submitted an efficacy supplement to NDA 21-361 for XIFAXAN® (rifaximin) 550 mg tablets for the proposed indication of treatment of non-constipation irritable bowel syndrome (Non-C IBS) and IBS-related bloating...View the full article
 
1 - 1 of 1 Posts
This is an older thread, you may not receive a response, and could be reviving an old thread. Please consider creating a new thread.
About this Discussion
0 Replies
1 Participant
Last post:
VSsupport
Irritable Bowel Syndrome and Digestive Health Support Forum
A forum community dedicated to Irritable Bowel Syndrome and Digestive Health Support. Come join the discussion about treatment, diet, health, lifestyles, spirituality, medication, research, recovery, and more!
Full Forum Listing
Explore Our Forums
General Discussion IBS Diarrhea (IBS-D) IBS Constipation (IBS-C) and Chronic Constipation Gas / Flatulence / Bloating Abdominal Pain
Recommended Communities
Community avatar for Overclocking
Overclocking
615K+ members
Community avatar for R32 Owners Club
R32 Owners Club
53K+ members
Community avatar for BMW EVs
BMW EVs
NEW!
10+ members
Top